June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Inhibition of Uncoupling Protein 2 Promotes Physiologic Retinal Vascularization via Activation of GLUT1 and S6K1
Author Affiliations & Notes
  • Xiaokun Han
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States
    Department of Ophthalmology, The Fourth Affiliated Hospital of China Medical University, Shenyang, China
  • Haibo Wang
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States
  • M Elizabeth Hartnett
    Department of Ophthalmology, Moran Eye Center, University of Utah, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Xiaokun Han, None; Haibo Wang, None; M Elizabeth Hartnett, None
  • Footnotes
    Support  Knights Templar, National Institutes of Health EY014800, R01EY015130, R01EY017011 and Unrestricted Grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3448. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Xiaokun Han, Haibo Wang, M Elizabeth Hartnett; Inhibition of Uncoupling Protein 2 Promotes Physiologic Retinal Vascularization via Activation of GLUT1 and S6K1. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3448.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinopathy of prematurity is characterized by delayed physiologic retinal vascular development (PRVD) and increased intravitreal neovascularization. We found that increased retinal uncoupling protein 2 (UCP2), a regulator of cellular glucose metabolism, was associated with reduced blood glucose in rat pups in an oxygen-induced retinopathy (OIR) model compared to room air-raised pups. Since cellular glucose metabolism is important for retinal vascular development, we postulated that inhibition of UCP2 would facilitate PRVD and reduce the risk of ROP and addressed this hypothesis using a rat model of OIR.

Methods : Within 4-6 hours of birth, Sprague-Dawley dams and pups (male and female) were placed into an Oxycycler that cycled oxygen between 50% and 10% oxygen every 24 hours. Rat pups in the OIR model received intraperitoneal injections of genipin (10 mg/kg), an UCP2 inhibitor, or equal volumes of PBS every other day beginning at postnatal day 3 (p3) and extending through p13. At p14, pups were euthanized and PRVD determined by avascular retinal area/total retinal area (AVA) was assessed in isolectin-stained retinal flatmounts. Retinal VEGF was measured by ELISA. Human retinal microvascular endothelial cells (hRMVECs) transfected with UCP2 siRNA or control siRNA, or pretreated with genipin (5 µM) or DMSO, were then stimulated with VEGF (50 ng/ml) or PBS for 30 mins. After treatments, glucose uptake was determined by 2-NBDG-2-Deoxyglucose. GLUT1, a dominant isoform of glucose transporter in the retinal cells, and phosphorylated S6K1 (p-S6K1), a regulator for cell growth, were measured by western blots. Statistics were performed using two-tailed Student’s t-test and results were Mean ± SEM.

Results : Compared to PBS-treated pups, genipin-treated pups had significantly less AVA (31.77±3.10 vs. PBS 45.52±4.61, p=0.03, n=13) and greater retinal VEGF protein (267±51.17 vs. PBS 181.31±12.18 pg/ml, p=0.02, n=6). Compared to control siRNA, GLUT1 protein and VEGF-induced p-S6K1 were increased in UCP2-transfected hRMVECs. Compared to control DMSO, glucose uptake was greater in hRMVECs treated with genipin (1.28±0.10 vs. DMSO 1.00±0.02, p=0.02, n=9).

Conclusions : Inhibition of UCP2 by genipin in the OIR model facilitated PRVD, potentially by increasing GLUT1 and VEGF-mediated S6K1 activation, which was found in cultured retinal endothelial cells.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×